What is the difference between a skin booster and a filler?
Both are often hyaluronic acid (HA), a sugar that binds water and occurs naturally in skin. The difference is where the gel goes and what it is built to do. A booster is placed in small amounts in the dermis, the layer that gives skin its thickness, to improve hydration, fine lines and texture. A filler is a firmer gel placed deeper to add volume, shape or support. The FDA summary for one volumising filler describes "deep (subcutaneous and/or supraperiosteal)" injection to correct age-related volume deficit in the mid-face. The summary for one booster describes intradermal injection to improve skin smoothness, with 32 G needles and microdroplets.
The word "booster" does not mean the gel is uncrosslinked. That same booster is HA crosslinked with BDDE, and the volumising filler is made of mostly crosslinked HA with some lightly crosslinked and uncrosslinked HA, so the line between them is drawn by depth and purpose more than by chemistry. Other boosters use uncrosslinked or lightly crosslinked HA, or polynucleotides, which are DNA fragments and not HA at all. The types of skinbooster are sorted in their own article, and what the evidence shows for polynucleotides in another. "Skin booster" is a trade term and not a regulatory class. In Chinese-speaking Malaysia, 水光针 is the search for a booster and 玻尿酸 is the word for hyaluronic acid, which is why one word can end up covering both.
Where does each one go, and why does depth matter?
Depth decides the effect. A booster deposited within the dermis spreads hydration through the skin that sits on top of it, which is why trials measure smoothness, fine lines and hydration. A filler placed under the skin or on the bone supports the structure, which is why its trial measured volume deficit. The two layers behave differently, and a gel placed in the wrong one gives the wrong result.
Depth also changes the risks. The 2023 systematic review of HA for skin quality lists the location and volume of injection among the factors behind nodule formation, and the filler summary links more adverse events to a larger injected volume and to older age. The skinbooster page and the dermal filler page describe how each is offered at the clinic, after assessment.
What does a skin booster change, and what does a filler change?
In the US booster study, 131 treated people were compared with 71 untreated people. At one month, 57.9% improved by at least one grade of cheek smoothness against 4.5%, and 58.3% improved in fine lines against 5.4%. The observed rate was 55.6% at six months. A 2023 systematic review of 13 studies found improvement in hydration, firmness, texture, radiance and elasticity with injected HA, with HA alone doing better than HA mixed with vitamins and other ingredients. Two studies of HA with a multivitamin solution found no significant clinical or histologic change, and the authors say large randomised trials are still needed.
In the filler study, 270 people were treated for age-related loss of mid-face volume. The median volume used was 6.6 mL, and 85.6% were responders at month 6. A responder improved by at least one grade on a volume scale. Polynucleotide boosters have a smaller evidence base: seven randomised trials with 183 participants, four in skin rejuvenation, which reported better wrinkle-related outcomes and no serious treatment-related adverse events, with the most consistent benefit in wound healing. In short, boosters are studied for skin quality, fillers for volume, and neither set of trials tests the other's job.
How many sessions are needed, and how long do the results last?
Booster protocols in the published studies vary. Several used three sessions about four weeks apart, one used four sessions at 15-day intervals, and one used a single session. In the US booster study, a touch-up was optional 30 days after the first treatment, the benefit was followed for six months, and in a European study of 131 people a repeat was offered at nine months. The filler study allowed up to two treatments a month apart and followed people for 24 months, with 85.2% responders at month 12 and 67.1% at month 24.
These are manufacturer-run studies of specific products, in specific areas, measured with specific scales. They do not give one number for "how long a booster lasts" or "how long a filler lasts", and no honest number can be given in advance for one person. What can be said is that the booster studies mostly used a short course of sessions, and the filler study used one treatment with an optional touch-up.
What are the side effects of each?
Both cause injection-site reactions: redness, swelling, tenderness, bruising and small lumps. In the US booster study, 79.4% of treated people recorded some reaction in the first 30 days, and the summary describes most as mild and lasting seven days or less. In the filler study, 98% had a treatment-site response, most often moderate and lasting two to four weeks, and 20.0% still had a response after 30 days, mainly lumps and firmness. The review of boosters found that bruising, swelling and tenderness typically lasted under two weeks.
Rarer problems include nodules, infection and allergic or delayed inflammatory reactions, and vascular occlusion appears in the post-market reports for both categories. These studies used different products, different people and different ways of recording reactions, so the figures show the shape of each and cannot rank them. The full list, timelines and what to do are in skin booster side effects, aftercare and who should wait.
When are a skin booster and a filler used together?
When assessment finds two separate problems, for example skin that is dull, dry and fine-lined and a face that has also lost volume. The booster works on the skin and the filler on what sits under it, so one does not stand in for the other. If the booster were asked to restore volume, or a filler asked to improve skin quality, neither would be doing the job it was made for.
The evidence for combining them is thin. No trial read for this article tested a booster and a filler in one plan, and the US booster study excluded anyone with facial filler in the previous 12 months, so those results say nothing about how the two behave together. The order, the gap between them and whether they happen in one visit are clinical decisions made from an assessment, and no study has settled them.
What do neither of them do?
Neither relaxes muscle, so expression lines that come from movement need a different treatment. Neither lifts or tightens sagging tissue by itself, neither reliably treats pigmentation such as melasma, and neither removes excess skin. What skinboosters fix, and what they never will sets the limits out for the booster side.
At The Retreat Clinic, skinboosters, including polynucleotides, and dermal fillers are both offered, after assessment. The assessment is where the choice is made, from what is found in the face.
